As scrutiny of pharmaceutical pricing intensifies, excessive pricing is emerging as a tangible enforcement risk within European competition law. Using the AbbVie v. PAF case in the Netherlands as a case study, this presentation explores how courts and authorities are reassessing pricing conduct and what this means for your future strategy.
Charmian Simmons
Principle Strategic Advisor, FinCrime Compliance
SymphonyAI
Charmian Simmons is a Principal Strategic Advisor for FinCrime Compliance, helping financial institutions navigate the evolving intersection of regulation, risk, technology and innovation. She has over 20 years of experience in the financial sector across risk management, financial crime, internal controls and IT advisory. A technology evangelist with a focus on AI-driven innovation and transformation, Charmian leverages her practitioner expertise and industry knowledge to provide strategic advisory services and thought leadership on the regulatory, policy and technology developments transforming financial crime compliance.
Prior to joining Symphony AI, Charmian was a FinCrime Expert with BAE Systems, a Regional Director of Strategy and Performance for the Risk business at Refinitiv, the Head of Audit in North America at Lloyds Banking Group USA and a Vice President at Morgan Stanley covering Capital Markets. Charmian is CAMS, CDPSE, CRMA and CISA certified.
Caroline Brown
Partner
Deloitte
Ramesh Panavalli
Head of Responsible Sourcing & Human Rights
Holland & Barrett
Fergal Brady
Patent Examiner
Intellectual Property Office of Ireland
Dylan Saunders
Senior Account Executive
Regrow Ag
Dylan Saunders works at Regrow Ag, supporting the development of data-driven solutions that help build more resilient and sustainable agricultural systems. With a background from the University of Colorado Boulder, he focuses on applying technology to drive measurable impact across global supply chains. When he's not working, you can find Dylan on a trail with his cattle dog, Rosie.
Richard Page
Partner
df-mp
Richard Page is a European Patent Attorney and a UPC Representative, specialising in life science patents. Drawing on his solid technical background as a researcher in the UK and Germany and fourteen years of IP experience, he advises clients across a broad range of life science technologies. He has particular expertise in antibody-related inventions, vaccines and second medical uses. Richard has a strong track record in opposition and appeal proceedings before the European Patent Office, and he brings his contentious insights into his drafting and prosecution work to help clients secure strategically robust and commercially valuable patent protection.
Vijay Sikka
Chairman and CEO
sikka.ai
Vijay Sikka
Chairman and CEO
sikka.ai
Adam Wysocki
President & Founder
VetSoftwareHub